Target intelligence / Profile preview

SPRY domain containing 7 pseudogene 1 (SPRYD7P1)

Target
SPRYD7P1
Molecular classification
Other (Pseudogene)
01

Overview

SPRY domain containing 7 pseudogene 1 (SPRYD7P1) is a non-protein-coding genomic locus annotated as a pseudogene of the SPRYD7 gene. Like other pseudogenes, SPRYD7P1 may act as a non-coding RNA, possibly influencing gene expression by mechanisms such as competing for microRNA binding sites (acting as a “miRNA decoy” or ceRNA), similar to functions documented for other pseudogenes like PTENP1 and KRASP1[1][5][7]. However, there is currently no direct experimental evidence that SPRYD7P1 has a functional impact in cancer or other diseases, nor is it recognized as a therapeutic target or biomarker[3][4]. The related functional gene, SPRYD7, is a protein coding gene associated with cancer progression, particularly in colorectal cancer, where its upregulation correlates with invasion, metastasis, angiogenesis, and poor prognosis[2][4]. This does not extend to the pseudogene SPRYD7P1, which lacks a protein product. Summary: SPRYPD7P1 is a pseudogene, does not produce a functional protein, is not a direct therapeutic target, and current knowledge does not associate it with specific disease or drug response roles[3][1][2].

Other names
SPRYD7P1
02

Biological functions

Potential regulation of gene expression as a non-coding RNA (by analogy to other pseudogenes, such as PTENP1 and KRASP1, which act as “miRNA decoys”)
03

Disease associations

Other (no direct evidence for disease role from available sources; disease relevance is possible for homologous protein-coding gene SPRYD7, which is associated with cancer progression/metastasis, but not for SPRYD7P1 specifically)

Beyond the preview

Go deeper on SPRY domain containing 7 pseudogene 1 (SPRYD7P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SPRY domain containing 7 pseudogene 1 (SPRYD7P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call